What is the most likely diagnosis and recommended diagnostic and treatment plan for a patient presenting with high‑arched feet (pes cavus), kyphoscoliosis, elevated lactate, and bilateral limb spasticity?

Mitochondrial Myopathy (Likely MELAS or Related Disorder)

This constellation of pes cavus, kyphoscoliosis, elevated lactate, and bilateral limb spasticity strongly suggests a mitochondrial myopathy rather than a peripheral neuropathy, and requires immediate metabolic workup including muscle biopsy, genetic testing for mitochondrial DNA mutations, and neuroimaging to assess for stroke-like lesions.

Diagnostic Reasoning

The elevated lactate is the critical distinguishing feature here. While the evidence provided focuses heavily on Charcot-Marie-Tooth disease (CMT) and hereditary motor-sensory neuropathies presenting with pes cavus and kyphoscoliosis 1, 2, 3, these conditions do not typically present with elevated lactate or spasticity.

Key Clinical Distinctions:

Upper Motor Neuron vs. Lower Motor Neuron:

• Bilateral limb spasticity indicates upper motor neuron involvement (corticospinal tract)
• CMT and hereditary neuropathies cause flaccid weakness with absent reflexes, not spasticity 2, 3
• This immediately shifts the differential away from pure peripheral neuropathies

Metabolic Red Flag:

• Elevated lactate suggests impaired oxidative phosphorylation
• This points toward mitochondrial disease, not hereditary neuropathy
• Mitochondrial disorders commonly present with multisystem involvement including skeletal deformities and neurological dysfunction

Recommended Diagnostic Workup

Immediate Priority Tests:

1. Serum lactate and pyruvate (fasting and post-exercise)

   • Calculate lactate/pyruvate ratio
   • Elevated ratio suggests mitochondrial dysfunction

2. Brain and spinal cord MRI with spectroscopy

   • Look for stroke-like lesions (MELAS)
   • Basal ganglia calcifications
   • White matter changes
   • Assess for structural spinal cord pathology causing spasticity

3. Muscle biopsy with specialized stains

   • Modified Gomori trichrome for ragged red fibers
   • Cytochrome c oxidase (COX) staining
   • Electron microscopy for abnormal mitochondria
   • Respiratory chain enzyme analysis

4. Genetic testing

   • Mitochondrial DNA sequencing (especially m.3243A>G for MELAS)
   • Nuclear DNA genes affecting mitochondrial function
   • Consider whole exome sequencing if initial panel negative

5. Comprehensive metabolic panel

   • Plasma amino acids
   • Urine organic acids
   • Creatine kinase (may be elevated 1)
   • Carnitine levels

Secondary Neurological Assessment:

• EMG/NCS: May show mixed picture but won't explain spasticity
• Ophthalmology exam: Check for ophthalmoplegia, retinopathy
• Audiology: Hearing loss common in mitochondrial disease
• Cardiac evaluation: ECG and echocardiogram (cardiomyopathy risk 1)

Treatment Approach

Acute Management:

• Avoid metabolic stressors: Fasting, extreme exercise, certain medications (valproate, aminoglycosides)
• Supportive care: Adequate hydration, avoid hypoglycemia
• Monitor for acute decompensation: Stroke-like episodes in MELAS

Chronic Management:

Pharmacological:

• Coenzyme Q10 (ubiquinone): 300-600 mg daily
• L-carnitine: 50-100 mg/kg/day (if deficient)
• B-vitamins: Thiamine, riboflavin, niacin supplementation
• Arginine: For MELAS specifically, may reduce stroke-like episodes

Orthopedic Considerations:

• The pes cavus and kyphoscoliosis require orthopedic evaluation 4, 5
• However, surgical correction should be deferred until metabolic stability achieved
• Progressive neurological disease may affect surgical outcomes
• Conservative management with orthotics initially 3, 5

Spasticity Management:

• Baclofen or tizanidine for symptomatic relief
• Physical therapy to prevent contractures
• Consider botulinum toxin for focal spasticity

Critical Pitfalls to Avoid

1. Do not assume CMT based solely on pes cavus and kyphoscoliosis - The spasticity and elevated lactate exclude typical CMT 1, 2, 3

2. Do not perform spinal surgery without ruling out metabolic disease - Anesthetic complications are higher in mitochondrial disorders

3. Do not delay muscle biopsy - This is often diagnostic and guides genetic testing

4. Screen family members - Maternal inheritance pattern for mitochondrial DNA mutations

5. Avoid sodium valproate and statins - Can precipitate metabolic crisis in mitochondrial disease

The evidence provided focuses on CMT and structural foot deformities 1, 6, 2, 4, 3, 5, 7, but none address the combination of elevated lactate with spasticity, which fundamentally changes the diagnostic approach toward mitochondrial or other metabolic disorders affecting both central and peripheral nervous systems.